FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100095241> ?p ?o ?g. }

• W2100095241 endingPage "1226" @default.
• W2100095241 startingPage "1217" @default.
• W2100095241 abstract "Previous reports from these authors found that activation of peroxisome proliferator-activated receptor gamma (PPARγ) suppressed hepatocellular carcinoma (HCC). This study sought to identify the molecular target of PPARγ and characterize its antitumor effect in HCC.Optimal PPARγ binding activity was obtained using the PPARγ agonist rosiglitazone (100 μM) as determined by enzyme-linked immunosorbent assay. Under PPARγ activation, 114 PPARγ downstream targets associated with cancer development were identified by oligonucleotide microarray and Gene Ontology analysis. Among them, Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 (CITED2) was the most prominent PPARγ-bound target, as determined by chromatin immunoprecipitation-polymerase chain reaction.CITED2 messenger RNA and protein was significantly down-regulated in primary HCCs compared with their adjacent nontumor tissues. PPARγ induced expression of CITED2 in HCC cell lines after adenovirus-PPARγ transduction. The biological function of CITED2 was evaluated by loss- and gain-of-function assays. CITED2 knockdown in the hepatocyte cell line LO2 and HCC cell line Hep3B significantly increased cell viability and clonogenicity, and promoted G1 -S phase transition in both cell lines. In contrast, ectopic expression of CITED2 in HepG2 and BEL7404 HCC cell lines significantly suppressed cell growth. The tumor suppressive effect of CITED2 was associated with up-regulation of cyclin-dependent kinase inhibitors p15(INK4B) , p21(Wat1/Cip1) , p27(Kip1) , antiproliferative regulator interferon alpha 1, proapoptotic mediators including tumor necrosis factor receptor superfamily member 1A (TNFRSF1A), TNFRSF25, caspase-8, granzyme A, and the tumor suppressor gene maspin. CITED2 was also associated with the down-regulation of cell cycle regulator cyclin D1, oncogene telomerase reverse transcriptase, and proinvasion/metastasis gene matrix metallopeptidase 2.CITED2 is a direct effector of PPARγ for tumor suppression. Cancer 2013. © 2012 American Cancer Society." @default.
• W2100095241 created "2016-06-24" @default.
• W2100095241 creator A5013525493 @default.
• W2100095241 creator A5033829154 @default.
• W2100095241 creator A5038112478 @default.
• W2100095241 creator A5049274840 @default.
• W2100095241 creator A5053186275 @default.
• W2100095241 creator A5055538725 @default.
• W2100095241 creator A5059410023 @default.
• W2100095241 creator A5087386608 @default.
• W2100095241 date "2012-12-04" @default.
• W2100095241 modified "2023-09-23" @default.
• W2100095241 title "CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth" @default.
• W2100095241 cites W17927793 @default.
• W2100095241 cites W1964672896 @default.
• W2100095241 cites W1974648187 @default.
• W2100095241 cites W1976898219 @default.
• W2100095241 cites W1981989535 @default.
• W2100095241 cites W1982027307 @default.
• W2100095241 cites W1983594174 @default.
• W2100095241 cites W1995365852 @default.
• W2100095241 cites W2002761352 @default.
• W2100095241 cites W2029080338 @default.
• W2100095241 cites W2040408629 @default.
• W2100095241 cites W2054154194 @default.
• W2100095241 cites W2069250127 @default.
• W2100095241 cites W2074235518 @default.
• W2100095241 cites W2077550626 @default.
• W2100095241 cites W2087310793 @default.
• W2100095241 cites W2091437415 @default.
• W2100095241 cites W2101031676 @default.
• W2100095241 cites W2140334270 @default.
• W2100095241 cites W2140715581 @default.
• W2100095241 cites W2141741548 @default.
• W2100095241 cites W2149873978 @default.
• W2100095241 cites W2157697601 @default.
• W2100095241 cites W2169165336 @default.
• W2100095241 cites W2171088586 @default.
• W2100095241 cites W2330418837 @default.
• W2100095241 cites W4294107304 @default.
• W2100095241 doi "https://doi.org/10.1002/cncr.27865" @default.
• W2100095241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23212831" @default.
• W2100095241 hasPublicationYear "2012" @default.
• W2100095241 type Work @default.
• W2100095241 sameAs 2100095241 @default.
• W2100095241 citedByCount "31" @default.
• W2100095241 countsByYear W21000952412014 @default.
• W2100095241 countsByYear W21000952412015 @default.
• W2100095241 countsByYear W21000952412016 @default.
• W2100095241 countsByYear W21000952412017 @default.
• W2100095241 countsByYear W21000952412018 @default.
• W2100095241 countsByYear W21000952412019 @default.
• W2100095241 countsByYear W21000952412020 @default.
• W2100095241 countsByYear W21000952412021 @default.
• W2100095241 countsByYear W21000952412022 @default.
• W2100095241 countsByYear W21000952412023 @default.
• W2100095241 crossrefType "journal-article" @default.
• W2100095241 hasAuthorship W2100095241A5013525493 @default.
• W2100095241 hasAuthorship W2100095241A5033829154 @default.
• W2100095241 hasAuthorship W2100095241A5038112478 @default.
• W2100095241 hasAuthorship W2100095241A5049274840 @default.
• W2100095241 hasAuthorship W2100095241A5053186275 @default.
• W2100095241 hasAuthorship W2100095241A5055538725 @default.
• W2100095241 hasAuthorship W2100095241A5059410023 @default.
• W2100095241 hasAuthorship W2100095241A5087386608 @default.
• W2100095241 hasConcept C104317684 @default.
• W2100095241 hasConcept C1292079 @default.
• W2100095241 hasConcept C153911025 @default.
• W2100095241 hasConcept C170493617 @default.
• W2100095241 hasConcept C187345961 @default.
• W2100095241 hasConcept C502942594 @default.
• W2100095241 hasConcept C53227056 @default.
• W2100095241 hasConcept C54355233 @default.
• W2100095241 hasConcept C55493867 @default.
• W2100095241 hasConcept C62112901 @default.
• W2100095241 hasConcept C81885089 @default.
• W2100095241 hasConcept C86339819 @default.
• W2100095241 hasConcept C86803240 @default.
• W2100095241 hasConceptScore W2100095241C104317684 @default.
• W2100095241 hasConceptScore W2100095241C1292079 @default.
• W2100095241 hasConceptScore W2100095241C153911025 @default.
• W2100095241 hasConceptScore W2100095241C170493617 @default.
• W2100095241 hasConceptScore W2100095241C187345961 @default.
• W2100095241 hasConceptScore W2100095241C502942594 @default.
• W2100095241 hasConceptScore W2100095241C53227056 @default.
• W2100095241 hasConceptScore W2100095241C54355233 @default.
• W2100095241 hasConceptScore W2100095241C55493867 @default.
• W2100095241 hasConceptScore W2100095241C62112901 @default.
• W2100095241 hasConceptScore W2100095241C81885089 @default.
• W2100095241 hasConceptScore W2100095241C86339819 @default.
• W2100095241 hasConceptScore W2100095241C86803240 @default.
• W2100095241 hasIssue "6" @default.
• W2100095241 hasLocation W21000952411 @default.
• W2100095241 hasLocation W21000952412 @default.
• W2100095241 hasOpenAccess W2100095241 @default.
• W2100095241 hasPrimaryLocation W21000952411 @default.
• W2100095241 hasRelatedWork W1536365131 @default.
• W2100095241 hasRelatedWork W1971056997 @default.

• next